Geoffrey Beran Rose insider trades: Pulmonx (LUNG) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Geoffrey reports to the SEC
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | LUNG | ↓ Sell | 7,879 | $2.26 | $18K | Direct | Sep 3, 2026 (2d) |
| Jun 1, 2026 | LUNG | ↓ Sell | 8,023 | $1.54 | $12K | Direct | Jun 3, 2026 (2d) |
| Mar 2, 2026 | LUNG | ↓ Sell | 7,732 | $1.43 | $11K | Direct | Mar 4, 2026 (2d) |
| Dec 1, 2025 | LUNG | ↓ Sell | 6,322 | $1.57 | $10K | Direct | Dec 3, 2025 (2d) |
| Sep 2, 2025 | LUNG | ↓ Sell | 6,543 | $1.60 | $10K | Direct | Sep 3, 2025 (1d) |
| Jun 2, 2025 | LUNG | ↓ Sell | 6,947 | $3.13 | $22K | Direct | Jun 4, 2025 (2d) |
| Mar 3, 2025 | LUNG | ↓ Sell | 5,779 | $7.13 | $41K | Direct | Mar 5, 2025 (2d) |
| Dec 2, 2024 | LUNG | ↓ Sell | 4,376 | $6.18 | $27K | Direct | Dec 4, 2024 (2d) |
| Sep 3, 2024 | LUNG | ↓ Sell | 4,586 | $6.70 | $31K | Direct | Sep 5, 2024 (2d) |
| Jun 24, 2024 | LUNG | ↓ Sell | 1,184 | $6.16 | $7K | Direct | Jun 26, 2024 (2d) |
| Jun 3, 2024 | LUNG | ↓ Sell | 4,297 | $6.97 | $30K | Direct | Jun 5, 2024 (2d) |
| May 22, 2024 | LUNG | ↓ Sell | 1,184 | $8.71 | $10K | Direct | May 23, 2024 (1d) |
| Apr 22, 2024 | LUNG | ↓ Sell | 1,184 | $7.49 | $9K | Direct | Apr 24, 2024 (2d) |
| Mar 22, 2024 | LUNG | ↓ Sell | 1,184 | $9.36 | $11K | Direct | Mar 26, 2024 (4d) |
| Mar 1, 2024 | LUNG | ↓ Sell | 3,097 | $9.06 | $28K | Direct | Mar 5, 2024 (4d) |
| Feb 22, 2024 | LUNG | ↓ Sell | 1,184 | $14.20 | $17K | Direct | Feb 26, 2024 (4d) |
| Jan 22, 2024 | LUNG | ↓ Sell | 1,184 | $13.13 | $16K | Direct | Jan 24, 2024 (2d) |
| Dec 22, 2023 | LUNG | ↓ Sell | 1,184 | $12.75 | $15K | Direct | Dec 27, 2023 (5d) |
| Dec 1, 2023 | LUNG | ↓ Sell | 2,868 | $10.34 | $30K | Direct | Dec 5, 2023 (4d) |
| Nov 22, 2023 | LUNG | ↓ Sell | 1,184 | $10.60 | $13K | Direct | Nov 27, 2023 (5d) |
| Oct 23, 2023 | LUNG | ↓ Sell | 1,184 | $8.35 | $10K | Direct | Oct 25, 2023 (2d) |
| Sep 22, 2023 | LUNG | ↓ Sell | 1,184 | $10.51 | $12K | Direct | Sep 26, 2023 (4d) |
| Sep 1, 2023 | LUNG | ↓ Sell | 2,843 | $10.01 | $28K | Direct | Sep 6, 2023 (5d) |
| Aug 23, 2023 | LUNG | ↓ Sell | 1,184 | $10.54 | $12K | Direct | Aug 25, 2023 (2d) |
| Jun 1, 2023 | LUNG | ↓ Sell | 2,845 | $11.48 | $33K | Direct | Jun 2, 2023 (1d) |
| Mar 1, 2023 | LUNG | ↓ Sell | 1,206 | $11.03 | $13K | Direct | Mar 3, 2023 (2d) |
| Dec 1, 2022 | LUNG | ↓ Sell | 1,055 | $5.93 | $6K | Direct | Dec 5, 2022 (4d) |
| Sep 1, 2022 | LUNG | ↓ Sell | 1,027 | $17.89 | $18K | Direct | Sep 6, 2022 (5d) |
| Jun 1, 2022 | LUNG | ↓ Sell | 1,011 | $18.05 | $18K | Direct | Jun 3, 2022 (2d) |
| Mar 1, 2022 | LUNG | ↓ Sell | 426 | $25.91 | $11K | Direct | Mar 3, 2022 (2d) |
| Dec 15, 2021 | LUNG | ↓ Sell | 22,000 | $30.55 | $672K | Direct | Dec 16, 2021 (1d) |
| Dec 1, 2021 | LUNG | ↓ Sell | 355 | $32.73 | $12K | Direct | Dec 3, 2021 (2d) |
| Nov 15, 2021 | LUNG | ↓ Sell | 7,000 | $39.94 | $280K | Direct | Nov 16, 2021 (1d) |
| Oct 15, 2021 | LUNG | ↓ Sell | 7,000 | $39.44 | $276K | Direct | Oct 18, 2021 (3d) |
| Sep 15, 2021 | LUNG | ↓ Sell | 7,000 | $38.12 | $267K | Direct | Sep 17, 2021 (2d) |
| Sep 1, 2021 | LUNG | ↓ Sell | 355 | $40.09 | $14K | Direct | Sep 3, 2021 (2d) |
| Aug 16, 2021 | LUNG | ↓ Sell | 7,000 | $36.71 | $257K | Direct | Aug 18, 2021 (2d) |
| Jul 15, 2021 | LUNG | ↓ Sell | 7,000 | $38.73 | $271K | Direct | Jul 19, 2021 (4d) |
| May 24, 2021 | LUNG | ↓ Sell | 4,797 | $40.88 | $196K | Direct | May 25, 2021 (1d) |
| May 10, 2021 | LUNG | ↓ Sell | 4,797 | $40.70 | $195K | Direct | May 11, 2021 (1d) |
| Apr 19, 2021 | LUNG | ↓ Sell | 4,797 | $43.24 | $207K | Direct | Apr 21, 2021 (2d) |
| Apr 5, 2021 | LUNG | ↓ Sell | 4,797 | $47.64 | $229K | Direct | Apr 6, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LUNG insiders
Open-market trades in the last 12 months
About Geoffrey Beran Rose's insider trades
Geoffrey Beran Rose is Chief Commercial Officer at Pulmonx (LUNG). Since Apr 5, 2021, Geoffrey has reported no open-market purchases and 42 sales worth $3.4M on SEC Form 4. In the last 12 months: 4 sales ($51K).
Their filings also include grants and awards (6 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LUNG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.